Industry Research Reports
Home > Reports > Chemical & Material > Global Valacyclovir Hydrochloride Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Valacyclovir Hydrochloride Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-11-08
Pages: 155 Pages
Report ld: 5377086
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Valacyclovir Hydrochloride market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
From a downstream perspective, Medicine accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Valacyclovir Hydrochloride leading manufacturers including Ambeed, Atul Ltd, BioCrick BioTech, BioVision Inc, Glentham Life Sciences Limited, HuaHai, Molekula Group, MuseChem, Pharmaffiliates, Shanghai Pufei Biotechnology, etc., dominate supply; the top five capture approximately % of global revenue, with Ambeed leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Valacyclovir Hydrochloride market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Ambeed
- Atul Ltd
- BioCrick BioTech
- BioVision Inc
- Glentham Life Sciences Limited
- HuaHai
- Molekula Group
- MuseChem
- Pharmaffiliates
- Shanghai Pufei Biotechnology
- Spectrum Chemical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity 97%
- Purity 98%
- Purity 99%
Segment by Application
- Medicine
- Chemical
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Valacyclovir Hydrochloride study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Valacyclovir Hydrochloride: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Valacyclovir Hydrochloride Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity 97%
1.2.3 Purity 98%
1.2.4 Purity 99%
1.3 Market Segmentation by Application
1.3.1 Global Valacyclovir Hydrochloride Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medicine
1.3.3 Chemical
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Valacyclovir Hydrochloride Revenue Estimates and Forecasts 2020-2031
2.2 Global Valacyclovir Hydrochloride Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Valacyclovir Hydrochloride Sales Estimates and Forecasts 2020-2031
2.4 Global Valacyclovir Hydrochloride Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Valacyclovir Hydrochloride Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Valacyclovir Hydrochloride Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Valacyclovir Hydrochloride Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity 97% Market Size by Manufacturers
4.5.2 Purity 98% Market Size by Manufacturers
4.5.3 Purity 99% Market Size by Manufacturers
4.6 Global Valacyclovir Hydrochloride Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Valacyclovir Hydrochloride Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Valacyclovir Hydrochloride Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Valacyclovir Hydrochloride Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Valacyclovir Hydrochloride Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Valacyclovir Hydrochloride Sales and Revenue by Type (2020-2031)
7.4 North America Valacyclovir Hydrochloride Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Valacyclovir Hydrochloride Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Valacyclovir Hydrochloride Sales and Revenue by Type (2020-2031)
8.4 Europe Valacyclovir Hydrochloride Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Valacyclovir Hydrochloride Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Valacyclovir Hydrochloride Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Valacyclovir Hydrochloride Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Valacyclovir Hydrochloride Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Valacyclovir Hydrochloride Sales and Revenue by Type (2020-2031)
10.4 Central and South America Valacyclovir Hydrochloride Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Valacyclovir Hydrochloride Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Valacyclovir Hydrochloride Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Valacyclovir Hydrochloride Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Valacyclovir Hydrochloride Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Ambeed
12.1.1 Ambeed Corporation Information
12.1.2 Ambeed Business Overview
12.1.3 Ambeed Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.1.4 Ambeed Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Ambeed Valacyclovir Hydrochloride Sales by Product in 2024
12.1.6 Ambeed Valacyclovir Hydrochloride Sales by Application in 2024
12.1.7 Ambeed Valacyclovir Hydrochloride Sales by Geographic Area in 2024
12.1.8 Ambeed Valacyclovir Hydrochloride SWOT Analysis
12.1.9 Ambeed Recent Developments
12.2 Atul Ltd
12.2.1 Atul Ltd Corporation Information
12.2.2 Atul Ltd Business Overview
12.2.3 Atul Ltd Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.2.4 Atul Ltd Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Atul Ltd Valacyclovir Hydrochloride Sales by Product in 2024
12.2.6 Atul Ltd Valacyclovir Hydrochloride Sales by Application in 2024
12.2.7 Atul Ltd Valacyclovir Hydrochloride Sales by Geographic Area in 2024
12.2.8 Atul Ltd Valacyclovir Hydrochloride SWOT Analysis
12.2.9 Atul Ltd Recent Developments
12.3 BioCrick BioTech
12.3.1 BioCrick BioTech Corporation Information
12.3.2 BioCrick BioTech Business Overview
12.3.3 BioCrick BioTech Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.3.4 BioCrick BioTech Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 BioCrick BioTech Valacyclovir Hydrochloride Sales by Product in 2024
12.3.6 BioCrick BioTech Valacyclovir Hydrochloride Sales by Application in 2024
12.3.7 BioCrick BioTech Valacyclovir Hydrochloride Sales by Geographic Area in 2024
12.3.8 BioCrick BioTech Valacyclovir Hydrochloride SWOT Analysis
12.3.9 BioCrick BioTech Recent Developments
12.4 BioVision Inc
12.4.1 BioVision Inc Corporation Information
12.4.2 BioVision Inc Business Overview
12.4.3 BioVision Inc Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.4.4 BioVision Inc Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 BioVision Inc Valacyclovir Hydrochloride Sales by Product in 2024
12.4.6 BioVision Inc Valacyclovir Hydrochloride Sales by Application in 2024
12.4.7 BioVision Inc Valacyclovir Hydrochloride Sales by Geographic Area in 2024
12.4.8 BioVision Inc Valacyclovir Hydrochloride SWOT Analysis
12.4.9 BioVision Inc Recent Developments
12.5 Glentham Life Sciences Limited
12.5.1 Glentham Life Sciences Limited Corporation Information
12.5.2 Glentham Life Sciences Limited Business Overview
12.5.3 Glentham Life Sciences Limited Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.5.4 Glentham Life Sciences Limited Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Glentham Life Sciences Limited Valacyclovir Hydrochloride Sales by Product in 2024
12.5.6 Glentham Life Sciences Limited Valacyclovir Hydrochloride Sales by Application in 2024
12.5.7 Glentham Life Sciences Limited Valacyclovir Hydrochloride Sales by Geographic Area in 2024
12.5.8 Glentham Life Sciences Limited Valacyclovir Hydrochloride SWOT Analysis
12.5.9 Glentham Life Sciences Limited Recent Developments
12.6 HuaHai
12.6.1 HuaHai Corporation Information
12.6.2 HuaHai Business Overview
12.6.3 HuaHai Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.6.4 HuaHai Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 HuaHai Recent Developments
12.7 Molekula Group
12.7.1 Molekula Group Corporation Information
12.7.2 Molekula Group Business Overview
12.7.3 Molekula Group Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.7.4 Molekula Group Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Molekula Group Recent Developments
12.8 MuseChem
12.8.1 MuseChem Corporation Information
12.8.2 MuseChem Business Overview
12.8.3 MuseChem Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.8.4 MuseChem Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 MuseChem Recent Developments
12.9 Pharmaffiliates
12.9.1 Pharmaffiliates Corporation Information
12.9.2 Pharmaffiliates Business Overview
12.9.3 Pharmaffiliates Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.9.4 Pharmaffiliates Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Pharmaffiliates Recent Developments
12.10 Shanghai Pufei Biotechnology
12.10.1 Shanghai Pufei Biotechnology Corporation Information
12.10.2 Shanghai Pufei Biotechnology Business Overview
12.10.3 Shanghai Pufei Biotechnology Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.10.4 Shanghai Pufei Biotechnology Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Shanghai Pufei Biotechnology Recent Developments
12.11 Spectrum Chemical
12.11.1 Spectrum Chemical Corporation Information
12.11.2 Spectrum Chemical Business Overview
12.11.3 Spectrum Chemical Valacyclovir Hydrochloride Product Models, Descriptions and Specifications
12.11.4 Spectrum Chemical Valacyclovir Hydrochloride Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Spectrum Chemical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Valacyclovir Hydrochloride Industry Chain
13.2 Valacyclovir Hydrochloride Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Valacyclovir Hydrochloride Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Valacyclovir Hydrochloride Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Valacyclovir Hydrochloride Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Valacyclovir Hydrochloride Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Valacyclovir Hydrochloride Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Valacyclovir Hydrochloride Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Valacyclovir Hydrochloride Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Valacyclovir Hydrochloride Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Valacyclovir Hydrochloride Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Valacyclovir Hydrochloride Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Valacyclovir Hydrochloride Sales by Region (2020-2025) & (Tons)
Table 8. Global Valacyclovir Hydrochloride Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Valacyclovir Hydrochloride Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Valacyclovir Hydrochloride Production by Region (2020-2025) & (Tons)
Table 12. Global Valacyclovir Hydrochloride Production by Region (2026-2031) & (Tons)
Table 13. Global Valacyclovir Hydrochloride Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Valacyclovir Hydrochloride Sales Share by Manufacturers (2020-2025)
Table 15. Global Valacyclovir Hydrochloride Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Valacyclovir Hydrochloride Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Valacyclovir Hydrochloride by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valacyclovir Hydrochloride as of 2024)
Table 19. Global Valacyclovir Hydrochloride Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Valacyclovir Hydrochloride Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Valacyclovir Hydrochloride Manufacturing Base and Headquarters
Table 22. Global Valacyclovir Hydrochloride Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Valacyclovir Hydrochloride Sales by Type (2020-2025) & (Tons)
Table 26. Global Valacyclovir Hydrochloride Sales by Type (2026-2031) & (Tons)
Table 27. Global Valacyclovir Hydrochloride Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Valacyclovir Hydrochloride Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Valacyclovir Hydrochloride ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Valacyclovir Hydrochloride Sales by Application (2020-2025) & (Tons)
Table 32. Global Valacyclovir Hydrochloride Sales by Application (2026-2031) & (Tons)
Table 33. Valacyclovir Hydrochloride High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Valacyclovir Hydrochloride Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Valacyclovir Hydrochloride Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Valacyclovir Hydrochloride ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Valacyclovir Hydrochloride Growth Accelerators and Market Barriers
Table 40. North America Valacyclovir Hydrochloride Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Valacyclovir Hydrochloride Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Valacyclovir Hydrochloride Growth Accelerators and Market Barriers
Table 43. Europe Valacyclovir Hydrochloride Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Valacyclovir Hydrochloride Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Valacyclovir Hydrochloride Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Valacyclovir Hydrochloride Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Valacyclovir Hydrochloride Growth Accelerators and Market Barriers
Table 48. Southeast Asia Valacyclovir Hydrochloride Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Valacyclovir Hydrochloride Investment Opportunities and Key Challenges
Table 50. Central and South America Valacyclovir Hydrochloride Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Valacyclovir Hydrochloride Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Valacyclovir Hydrochloride Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Ambeed Corporation Information
Table 54. Ambeed Description and Major Businesses
Table 55. Ambeed Product Models, Descriptions and Specifications
Table 56. Ambeed Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Ambeed Sales Value Proportion by Product in 2024
Table 58. Ambeed Sales Value Proportion by Application in 2024
Table 59. Ambeed Sales Value Proportion by Geographic Area in 2024
Table 60. Ambeed Valacyclovir Hydrochloride SWOT Analysis
Table 61. Ambeed Recent Developments
Table 62. Atul Ltd Corporation Information
Table 63. Atul Ltd Description and Major Businesses
Table 64. Atul Ltd Product Models, Descriptions and Specifications
Table 65. Atul Ltd Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Atul Ltd Sales Value Proportion by Product in 2024
Table 67. Atul Ltd Sales Value Proportion by Application in 2024
Table 68. Atul Ltd Sales Value Proportion by Geographic Area in 2024
Table 69. Atul Ltd Valacyclovir Hydrochloride SWOT Analysis
Table 70. Atul Ltd Recent Developments
Table 71. BioCrick BioTech Corporation Information
Table 72. BioCrick BioTech Description and Major Businesses
Table 73. BioCrick BioTech Product Models, Descriptions and Specifications
Table 74. BioCrick BioTech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. BioCrick BioTech Sales Value Proportion by Product in 2024
Table 76. BioCrick BioTech Sales Value Proportion by Application in 2024
Table 77. BioCrick BioTech Sales Value Proportion by Geographic Area in 2024
Table 78. BioCrick BioTech Valacyclovir Hydrochloride SWOT Analysis
Table 79. BioCrick BioTech Recent Developments
Table 80. BioVision Inc Corporation Information
Table 81. BioVision Inc Description and Major Businesses
Table 82. BioVision Inc Product Models, Descriptions and Specifications
Table 83. BioVision Inc Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. BioVision Inc Sales Value Proportion by Product in 2024
Table 85. BioVision Inc Sales Value Proportion by Application in 2024
Table 86. BioVision Inc Sales Value Proportion by Geographic Area in 2024
Table 87. BioVision Inc Valacyclovir Hydrochloride SWOT Analysis
Table 88. BioVision Inc Recent Developments
Table 89. Glentham Life Sciences Limited Corporation Information
Table 90. Glentham Life Sciences Limited Description and Major Businesses
Table 91. Glentham Life Sciences Limited Product Models, Descriptions and Specifications
Table 92. Glentham Life Sciences Limited Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Glentham Life Sciences Limited Sales Value Proportion by Product in 2024
Table 94. Glentham Life Sciences Limited Sales Value Proportion by Application in 2024
Table 95. Glentham Life Sciences Limited Sales Value Proportion by Geographic Area in 2024
Table 96. Glentham Life Sciences Limited Valacyclovir Hydrochloride SWOT Analysis
Table 97. Glentham Life Sciences Limited Recent Developments
Table 98. HuaHai Corporation Information
Table 99. HuaHai Description and Major Businesses
Table 100. HuaHai Product Models, Descriptions and Specifications
Table 101. HuaHai Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. HuaHai Recent Developments
Table 103. Molekula Group Corporation Information
Table 104. Molekula Group Description and Major Businesses
Table 105. Molekula Group Product Models, Descriptions and Specifications
Table 106. Molekula Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Molekula Group Recent Developments
Table 108. MuseChem Corporation Information
Table 109. MuseChem Description and Major Businesses
Table 110. MuseChem Product Models, Descriptions and Specifications
Table 111. MuseChem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. MuseChem Recent Developments
Table 113. Pharmaffiliates Corporation Information
Table 114. Pharmaffiliates Description and Major Businesses
Table 115. Pharmaffiliates Product Models, Descriptions and Specifications
Table 116. Pharmaffiliates Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Pharmaffiliates Recent Developments
Table 118. Shanghai Pufei Biotechnology Corporation Information
Table 119. Shanghai Pufei Biotechnology Description and Major Businesses
Table 120. Shanghai Pufei Biotechnology Product Models, Descriptions and Specifications
Table 121. Shanghai Pufei Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 122. Shanghai Pufei Biotechnology Recent Developments
Table 123. Spectrum Chemical Corporation Information
Table 124. Spectrum Chemical Description and Major Businesses
Table 125. Spectrum Chemical Product Models, Descriptions and Specifications
Table 126. Spectrum Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 127. Spectrum Chemical Recent Developments
Table 128. Key Raw Materials Distribution
Table 129. Raw Materials Key Suppliers
Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 131. Milestones in Production Technology Evolution
Table 132. Distributors List
Table 133. Market Trends and Market Evolution
Table 134. Market Drivers and Opportunities
Table 135. Market Challenges, Risks, and Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Valacyclovir Hydrochloride Product Picture
Figure 2. Global Valacyclovir Hydrochloride Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Purity 97% Product Picture
Figure 4. Purity 98% Product Picture
Figure 5. Purity 99% Product Picture
Figure 6. Global Valacyclovir Hydrochloride Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Medicine
Figure 8. Chemical
Figure 9. Others
Figure 10. Valacyclovir Hydrochloride Report Years Considered
Figure 11. Global Valacyclovir Hydrochloride Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 13. Global Valacyclovir Hydrochloride Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Valacyclovir Hydrochloride Revenue Market Share by Region (2020-2031)
Figure 15. Global Valacyclovir Hydrochloride Sales (2020-2031) & (Tons)
Figure 16. Global Valacyclovir Hydrochloride Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global Valacyclovir Hydrochloride Sales Market Share by Region (2020-2031)
Figure 18. Global Valacyclovir Hydrochloride Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 19. Global Valacyclovir Hydrochloride Production Trend by Region (2020-2031) (Tons)
Figure 20. Global Valacyclovir Hydrochloride Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Valacyclovir Hydrochloride Production Growth Rate in North America (2020-2031) & (Tons)
Figure 23. Valacyclovir Hydrochloride Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 24. Valacyclovir Hydrochloride Production Growth Rate in China (2020-2031) & (Tons)
Figure 25. Valacyclovir Hydrochloride Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 26. Top 5 and Top 10 Manufacturers Valacyclovir Hydrochloride Sales Volume Market Share in 2024
Figure 27. Global Valacyclovir Hydrochloride Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. Purity 97% Revenue Market Share by Manufacturer in 2024
Figure 30. Purity 98% Revenue Market Share by Manufacturer in 2024
Figure 31. Purity 99% Revenue Market Share by Manufacturer in 2024
Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 34. Global Valacyclovir Hydrochloride Sales Market Share by Type (2020-2031)
Figure 35. Global Valacyclovir Hydrochloride Revenue Market Share by Type (2020-2031)
Figure 36. Global Valacyclovir Hydrochloride Sales Market Share by Application (2020-2031)
Figure 37. Global Valacyclovir Hydrochloride Revenue Market Share by Application (2020-2031)
Figure 38. North America Valacyclovir Hydrochloride Sales YoY (2020-2031) & (Tons)
Figure 39. North America Valacyclovir Hydrochloride Revenue YoY (2020-2031) & (US$ Million)
Figure 40. North America Top 5 Manufacturers Valacyclovir Hydrochloride Sales Revenue (US$ Million) in 2024
Figure 41. North America Valacyclovir Hydrochloride Sales Volume (Tons) by Type (2020- 2031)
Figure 42. North America Valacyclovir Hydrochloride Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 43. North America Valacyclovir Hydrochloride Sales Volume (Tons) by Application (2020-2031)
Figure 44. North America Valacyclovir Hydrochloride Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. US Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 46. Canada Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 47. Mexico Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 48. Europe Valacyclovir Hydrochloride Sales YoY (2020-2031) & (Tons)
Figure 49. Europe Valacyclovir Hydrochloride Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Europe Top 5 Manufacturers Valacyclovir Hydrochloride Sales Revenue (US$ Million) in 2024
Figure 51. Europe Valacyclovir Hydrochloride Sales Volume (Tons) by Type (2020-2031)
Figure 52. Europe Valacyclovir Hydrochloride Sales Revenue (US$ Million) by Type (2020-2031)
Figure 53. Europe Valacyclovir Hydrochloride Sales Volume (Tons) by Application (2020-2031)
Figure 54. Europe Valacyclovir Hydrochloride Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Germany Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 56. France Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 57. U.K. Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 58. Italy Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 59. Russia Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Valacyclovir Hydrochloride Sales YoY (2020-2031) & (Tons)
Figure 61. Asia-Pacific Valacyclovir Hydrochloride Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Top 8 Manufacturers Valacyclovir Hydrochloride Sales Revenue (US$ Million) in 2024
Figure 63. Asia-Pacific Valacyclovir Hydrochloride Sales Volume (Tons) by Type (2020- 2031)
Figure 64. Asia-Pacific Valacyclovir Hydrochloride Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 65. Asia-Pacific Valacyclovir Hydrochloride Sales Volume (Tons) by Application (2020-2031)
Figure 66. Asia-Pacific Valacyclovir Hydrochloride Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Indonesia Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 68. Japan Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 69. South Korea Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 70. China Taiwan Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 71. India Valacyclovir Hydrochloride Revenue (2020-2031) & (US$ Million)
Figure 72. Central and South America Valacyclovir Hydrochloride Sales YoY (2020-2031) & (Tons)
Figure 73. Central and South America Valacyclovir Hydrochloride Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Central and South America Top 5 Manufacturers Valacyclovir Hydrochloride Sales Revenue (US$ Million) in 2024
Figure 75. Central and South America Valacyclovir Hydrochloride Sales Volume (Tons) by Type (2021-2031)
Figure 76. Central and South America Valacyclovir Hydrochloride Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Central and South America Valacyclovir Hydrochloride Sales Volume (Tons) by Application (2020-2031)
Figure 78. Central and South America Valacyclovir Hydrochloride Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. Brazil Valacyclovir Hydrochloride Revenue (2020-2025) & (US$ Million)
Figure 80. Argentina Valacyclovir Hydrochloride Revenue (2020-2025) & (US$ Million)
Figure 81. Middle East, and Africa Valacyclovir Hydrochloride Sales YoY (2020-2031) & (Tons)
Figure 82. Middle East and Africa Valacyclovir Hydrochloride Revenue YoY (2020-2031) & (US$ Million)
Figure 83. Middle East and Africa Top 5 Manufacturers Valacyclovir Hydrochloride Sales Revenue (US$ Million) in 2024
Figure 84. Middle East and Africa Valacyclovir Hydrochloride Sales Volume (Tons) by Type (2021-2031)
Figure 85. South America Valacyclovir Hydrochloride Sales Revenue (US$ Million) by Type (2020-2031)
Figure 86. Middle East and Africa Valacyclovir Hydrochloride Sales Volume (Tons) by Application (2020-2031)
Figure 87. Middle East and Africa Valacyclovir Hydrochloride Sales Revenue (US$ Million) by Application (2020-2031)
Figure 88. GCC Countries Valacyclovir Hydrochloride Revenue (2020-2025) & (US$ Million)
Figure 89. Turkey Valacyclovir Hydrochloride Revenue (2020-2025) & (US$ Million)
Figure 90. Egypt Valacyclovir Hydrochloride Revenue (2020-2025) & (US$ Million)
Figure 91. South Africa Valacyclovir Hydrochloride Revenue (2020-2025) & (US$ Million)
Figure 92. Valacyclovir Hydrochloride Industry Chain Mapping
Figure 93. Regional Valacyclovir Hydrochloride Manufacturing Base Distribution (%)
Figure 94. Valacyclovir Hydrochloride Production Process
Figure 95. Regional Valacyclovir Hydrochloride Production Cost Structure
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Valacyclovir Hydrochloride market?
The top companies in the global Valacyclovir Hydrochloride market are Ambeed、Atul Ltd、BioCrick BioTech.
Related Reports
Valacyclovir Hydrochloride- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Valacyclovir Hydrochloride was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
Global Valacyclovir Hydrochloride Market Research Report 2026
The global Valacyclovir Hydrochloride market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 137
USD 2900.00
(Single User License)
Global Valacyclovir Hydrochloride Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Valacyclovir Hydrochloride market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 93
USD 4250.00
(Single User License)
Global Valacyclovir Hydrochloride Market Research Report 2025
The global market for Valacyclovir Hydrochloride was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-09
Pages: 100
USD 2900.00
(Single User License)
Valacyclovir Hydrochloride- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Valacyclovir Hydrochloride was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 120
USD 3950.00
(Single User License)
Global Valacyclovir Hydrochloride Market Insights, Forecast to 2030
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published Date: 2024-04-12
Pages: 109
USD 4900.00
(Single User License)
Global Valacyclovir Hydrochloride Market Research Report 2024
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published Date: 2024-01-17
Pages: 99
USD 2900.00
(Single User License)
Valacyclovir Hydrochloride - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published Date: 2024-01-07
Pages: 123
USD 3950.00
(Single User License)
Valacyclovir Hydrochloride- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Valacyclovir Hydrochloride was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 139
USD 3950.00 (Single User License)Global Valacyclovir Hydrochloride Market Research Report 2026
The global Valacyclovir Hydrochloride market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 137
USD 2900.00 (Single User License)Global Valacyclovir Hydrochloride Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Valacyclovir Hydrochloride market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 93
USD 4250.00 (Single User License)Global Valacyclovir Hydrochloride Market Research Report 2025
The global market for Valacyclovir Hydrochloride was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-09
Pages: 100
USD 2900.00 (Single User License)Valacyclovir Hydrochloride- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Valacyclovir Hydrochloride was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 120
USD 3950.00 (Single User License)Global Valacyclovir Hydrochloride Market Insights, Forecast to 2030
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published: 2024-04-12
Pages: 109
USD 4900.00 (Single User License)Global Valacyclovir Hydrochloride Market Research Report 2024
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published: 2024-01-17
Pages: 99
USD 2900.00 (Single User License)Valacyclovir Hydrochloride - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Valacyclovir hydrochloride hydrate is the L-valine ester of acyclovir and the prodrug of acyclovir. After entering the body, it is immediately hydrolyzed into acyclovir to exert its efficacy. It is used for the treatment of varicella-zoster and infections caused by type I and type II herpes simplex virus, including initial and recurrent genital herpes virus infections.
Published: 2024-01-07
Pages: 123
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now